User profiles for "author:C Roufosse"
Candice RoufosseImperial Colllege Healthcare NHS Trust Verified email at imperial.nhs.uk Cited by 2448 |
[HTML][HTML] A 2018 reference guide to the Banff classification of renal allograft pathology
C Roufosse, N Simmonds… - …, 2018 - journals.lww.com
A 2018 Reference Guide to the Banff Classification of Renal... : Transplantation A 2018
Reference Guide to the Banff Classification of Renal Allograft Pathology : Transplantation Log …
Reference Guide to the Banff Classification of Renal Allograft Pathology : Transplantation Log …
Circulating mesenchymal stem cells
CA Roufosse, NC Direkze, WR Otto… - The international journal of …, 2004 - Elsevier
Mesenchymal precursor cells (MPCs) are multipotent cells capable of differentiating into
various mesenchymal tissues, such as bone, cartilage, fat, tendon and muscle. They are …
various mesenchymal tissues, such as bone, cartilage, fat, tendon and muscle. They are …
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for …
M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz… - 2018 - Wiley Online Library
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …
[HTML][HTML] The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology
…, M Rabant, P Randhawa, EF Reed, C Roufosse… - American journal of …, 2017 - Elsevier
The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody …
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody …
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection
The XV. Banff conference for allograft pathology was held in conjunction with the annual
meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh …
meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh …
[HTML][HTML] Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
Background Severe COVID-19 has a high mortality rate. Comprehensive pathological
descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the …
descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the …
De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy
…, A Mclean, TH Cook, T Cairns, C Roufosse… - …, 2012 - journals.lww.com
Background The importance of human leukocyte antigen (HLA) matching in renal
transplantation is well recognized, with HLA-DR compatibility having the greatest influence …
transplantation is well recognized, with HLA-DR compatibility having the greatest influence …
Bone marrow‐derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome
EI Prodromidi, R Poulsom, R Jeffery, CA Roufosse… - Stem …, 2006 - academic.oup.com
In a model of autosomally recessive Alport syndrome, mice that lack the α3 chain of collagen
IV (Col4 α 3−/−) develop progressive glomerular damage leading to renal failure. The …
IV (Col4 α 3−/−) develop progressive glomerular damage leading to renal failure. The …
[HTML][HTML] Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and …
This meeting report from the XV Banff conference describes the creation of a multiorgan
transplant gene panel by the Banff Molecular Diagnostics Working Group (MDWG). This …
transplant gene panel by the Banff Molecular Diagnostics Working Group (MDWG). This …
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy
GM Lord, M Hollstein, VM Arlt, C Roufosse… - American Journal of …, 2004 - Elsevier
Background: Aristolochic acid-associated nephropathy (AAN) is a specific type of renal
disease that predisposes patients to a high risk of urothelial carcinoma. The authors have …
disease that predisposes patients to a high risk of urothelial carcinoma. The authors have …